Semler Scientific
Renae Cormier has extensive work experience in finance and investment. Renae is currently serving as the Chief Financial Officer at Semler Scientific since May 2022. Prior to that, they worked at Aravt Global LLC from 2013 to 2022 as a Partner, where they focused on global public equities and conducted in-depth research for portfolio investments. Renae also worked at Ziff Brothers Investments from 2001 to 2010, where they served as a Director of Financial Research and a ZBI Equities - Equity Analyst. In these roles, they analyzed companies and industries, made investment recommendations, and led a team responsible for investment research and forensic accounting analysis. Before that, Renae worked at PricewaterhouseCoopers from 1997 to 2001, where they served as a Manager Transaction Advisory Services and an Audit Senior, providing due diligence and transaction structuring services for mergers and acquisitions.
Renae Cormier holds a Bachelor's degree in Accounting and Finance, which they obtained from the University of Colorado Denver. Renae graduated with Magna Cum Laude honors. Additionally, they have an inactive CPA certification from the institution Certified Public Accountant (CPA). The obtained month and year for this certification are not provided.
This person is not in any offices
Semler Scientific
1 followers
Semler Scientific, Inc. is a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Semler Scientific's mission is to develop, manufacture and market innovative products that assist its customers in evaluating and treating chronic diseases. Semler Scientific commercially launched its first patented and FDA- cleared product in 2011, and received FDA 510(k) clearance for QuantaFlo®, the next generation version of this product, in 2015. QuantaFlo® is a rapid point-of-care test that measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease. QuantaFlo® is used by Semler Scientific's customers to more comprehensively evaluate their patients for risk of heart attacks and strokes. Semler Scientific believes it is positioned to provide valuable information to its insurance company and physician customers, which in turn permits them to better guide patient care.